{"id":"maxitrol","safety":{"commonSideEffects":[{"rate":null,"effect":"Ocular irritation or discomfort"},{"rate":null,"effect":"Allergic contact dermatitis"},{"rate":null,"effect":"Secondary infection (if steroid masks infection)"},{"rate":null,"effect":"Elevated intraocular pressure (with prolonged use)"}]},"_chembl":null,"_dailymed":{"setId":"ecfb954f-5554-0ad2-e053-2995a90a7516","title":"MAXITROL (NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE) SUSPENSION [HARROW EYE, LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Maxitrol combines dexamethasone (a potent corticosteroid) with neomycin and polymyxin B sulfates (broad-spectrum antibiotics). The dexamethasone suppresses inflammatory responses in ocular tissues, while the antibiotics provide coverage against common bacterial pathogens that may complicate inflammatory eye conditions.","oneSentence":"Maxitrol is a topical ophthalmic combination that reduces inflammation and bacterial infection in the eye through corticosteroid and antibiotic action.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:20:21.201Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Steroid-responsive inflammatory ocular conditions with bacterial infection or risk thereof"},{"name":"Post-operative ocular inflammation and infection prophylaxis"}]},"trialDetails":[{"nctId":"NCT02792036","phase":"PHASE1","title":"Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2016-11-01","conditions":"Retinoblastoma","enrollment":8},{"nctId":"NCT01227863","phase":"PHASE3","title":"Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis","status":"UNKNOWN","sponsor":"Azidus Brasil","startDate":"2011-02","conditions":"Bacterial Conjunctivitis, Acute","enrollment":70}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Anti-infective"],"phase":"marketed","status":"active","brandName":"Maxitrol®","genericName":"Maxitrol®","companyName":"St. Jude Children's Research Hospital","companyId":"st-jude-children-s-research-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Maxitrol is a topical ophthalmic combination that reduces inflammation and bacterial infection in the eye through corticosteroid and antibiotic action. Used for Steroid-responsive inflammatory ocular conditions with bacterial infection or risk thereof, Post-operative ocular inflammation and infection prophylaxis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}